Aberrant gene expression profiles can serve as biomarkers for the diagnosis and prognosis of cancer. For instance, the expression levels of certain genes can help distinguish between different cancer types or predict patient outcomes. Gene expression signatures are also used to tailor personalized treatment plans, enhancing the efficacy of targeted therapies.
